)
Palatin Technologies (PTN) investor relations material
Palatin Technologies Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Technology platform and expertise
Focus on melanocortin system, specifically MC4R agonists for syndromic and genetic obesity.
First to gain FDA approval for a melanocortin agent (Vyleesi® for female sexual dysfunction).
Demonstrated ability to move programs from discovery to FDA approval.
Strategy leverages deep expertise in melanocortin biology and chemistry.
Leadership and team
Leadership team with extensive experience in drug development, finance, and business development.
Key executives have backgrounds at major pharma companies and decades of industry experience.
Development pipeline and programs
Developing next-generation MC4R selective agonists for rare neuroendocrine diseases: HO, PWS, and BBS.
Pipeline includes both once-weekly injectable peptides and daily oral small molecules.
Phase 1 trials for peptides start 1H 2027, with Phase 2/3 in 2H 2027; oral small molecule Phase 1 starts 2H 2027.
MC4R pathway is validated for obesity management, with significant unmet need in rare diseases.
- Advancing next-gen MC4R agonists for rare obesity with strong pipeline, partnerships, and financials.PTN
Corporate presentation - Proxy covers director elections, auditor ratification, equity plan changes, and executive pay.PTN
Proxy filing - Next-gen MC4R agonists for rare obesity syndromes advance toward clinical trials in 2026–2027.PTN
Corporate presentation - Advancing selective MC4R agonists for rare obesity, with key clinical and partnership milestones ahead.PTN
Corporate presentation - Licensing revenue growth and pipeline progress support operations through mid-2027.PTN
Q3 2026 - Advancing MC4R agonists for rare obesity, with strong pipeline and strategic partnerships.PTN
Corporate presentation - Advancing MC4R agonists for rare obesity and forging key partnerships for future growth.PTN
Corporate presentation - MC4R-based obesity pipeline advances with strong cash reserves and key clinical milestones ahead.PTN
Q2 2026 - Net loss of $29.7M, asset sale, and pipeline progress set stage for key 2024–2025 milestones.PTN
Q4 2024
Next Palatin Technologies earnings date
Next Palatin Technologies earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)